ASCEND BIOPHARMACEUTICALS LTD has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are FREQUENCY THERAPEUTICS INC, STABILITECH BIOPHARMA LTD and TAKEUCHI HIROFUMI.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Macromolecular chemistry and polymers | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Heterocyclic compounds | |
#6 | Polysaccharides | |
#7 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Leong Clement | 16 |
#2 | Pietersz Geoffrey Allan | 6 |
#3 | Pietersz Geoffrey Alan | 4 |
Publication | Filing date | Title |
---|---|---|
AU2019210698A1 | Enhanced viral delivery formulation | |
EP3487999A1 | Methods of treating cancer | |
AU2012334825A1 | Immunomodulatory conjugates |